<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09700000_1</Organism_ID>
  <Organism>Mouse</Organism>
  <Organism_Latin>Mus musculus</Organism_Latin>
  <UniProt_ID>P06869</UniProt_ID>
  <Seq_Length>433</Seq_Length>
  <Molecule_Weight>48268</Molecule_Weight>
  <KEGG_ID>mmu:18792</KEGG_ID>
  <Orthology_ID>K01348</Orthology_ID>
  <Function_Summary>Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.</Function_Summary>
  <Catalytic_Mechanism>Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.</Catalytic_Mechanism>
  <Pfam_ID>PF00051:Kringle@@PF00089:Trypsin</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>uPA</Alias>
      <Alias>Urokinase-type plasminogen activator long chain A</Alias>
      <Alias>Urokinase-type plasminogen activator chain B</Alias>
      <Alias>Urokinase-type plasminogen activator short chain A</Alias>
      <Alias>U-plasminogen activator</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of smooth muscle cell migration.</Detail>
      <Keyword>Regulation of smooth muscle cell migration</Keyword>
      <Ontology_ID>GO:0014910</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of smooth muscle cell-matrix adhesion.</Detail>
      <Keyword>Regulation of smooth muscle cell-matrix adhesion</Keyword>
      <Ontology_ID>GO:2000097</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Regulation of receptor activity</Keyword>
      <Ontology_ID>GO:0010469</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism.</Detail>
      <Keyword>Smooth muscle cell migration</Keyword>
      <Ontology_ID>GO:0014909</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cell proliferation.</Detail>
      <Keyword>Regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0042127</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.</Detail>
      <Keyword>Regulation of cell adhesion mediated by integrin</Keyword>
      <Ontology_ID>GO:0033628</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An ongoing process that solubilizes fibrin, chiefly by the proteolytic action of plasmin, resulting in the removal of small blood clots.</Detail>
      <Keyword>Fibrinolysis</Keyword>
      <Ontology_ID>GO:0042730</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.</Detail>
      <Keyword>Response to hypoxia</Keyword>
      <Ontology_ID>GO:0001666</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>159</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MKVWLASLFLCALVVKNSEGGSVLGAPDESNCGCQNGGVCVSYKYFSRIRRCSCPRKFQGEHCEIDASKTCYHGNGDSYRGKANTDTKGRPCLAWNAPAVLQKPYNAHRPDAISLGLGKHNYCRNPDNQKRPWCYVQIGLRQFVQECMVHDCSLSKKPSSSVDQQGFQCGQKALRPRFKIVGGEFTEVENQPWFAAIYQKNKGGSPPSFKCGGSLISPCWVASAAHCFIQLPKKENYVVYLGQSKESSYNPGEMKFEVEQLILHEYYREDSLAYHNDIALLKIRTSTGQCAQPSRSIQTICLPPRFTDAPFGSDCEITGFGKESESDYLYPKNLKMSVVKLVSHEQCMQPHYYGSEINYKMLCAADPEWKTDSCKGDSGGPLICNIEGRPTLSGIVSWGRGCAEKNKPGVYTRVSHFLDWIQSHIGEEKGLAF</Protein_Seq>
    <DNA_Seq>GTAGCCCCAGAGCTCTGTCTGTCATCCATCCAGTCCTTGCGTGTCTGCCAGCGCCCTTCCGCTGCAGTCACCGAACTGCTGTCTAGAGCCCAGCGGCACTACCATGAAAGTCTGGCTGGCGAGCCTGTTCCTCTGCGCCTTGGTGGTGAAAAACTCTGAAGGTGGCAGTGTACTTGGAGCTCCTGATGAATCAAACTGTGGCTGTCAGAACGGAGGTGTATGCGTGTCCTACAAGTACTTCTCCAGAATTCGCCGATGCAGCTGCCCAAGGAAATTCCAGGGGGAGCACTGTGAGATAGATGCATCAAAAACCTGCTATCATGGAAATGGTGACTCTTACCGAGGAAAGGCCAACACTGATACCAAAGGTCGGCCCTGCCTGGCCTGGAATGCGCCTGCTGTCCTTCAGAAACCCTACAATGCCCACAGACCTGATGCTATTAGCCTAGGCCTGGGGAAACACAATTACTGCAGGAACCCTGACAACCAGAAGCGACCCTGGTGCTATGTGCAGATTGGCCTAAGGCAGTTTGTCCAAGAATGCATGGTGCATGACTGCTCTCTTAGCAAAAAGCCTTCTTCGTCTGTAGACCAACAAGGCTTCCAGTGTGGCCAGAAGGCTCTAAGGCCCCGCTTTAAGATTGTTGGGGGAGAATTCACTGAGGTGGAGAACCAGCCCTGGTTCGCAGCCATCTACCAGAAGAACAAGGGAGGAAGTCCTCCCTCCTTTAAATGTGGTGGGAGTCTCATCAGTCCTTGCTGGGTGGCCAGTGCCGCACACTGCTTCATTCAACTCCCAAAGAAGGAAAACTACGTTGTCTACCTGGGTCAGTCGAAGGAGAGCTCCTATAATCCTGGAGAGATGAAGTTTGAGGTGGAGCAGCTCATCTTGCACGAATACTACAGGGAAGACAGCCTGGCCTACCATAATGATATTGCCTTGCTGAAGATACGTACCAGCACGGGCCAATGTGCACAGCCATCCAGGTCCATACAGACCATCTGCCTGCCCCCAAGGTTTACTGATGCTCCGTTTGGTTCAGACTGTGAGATCACTGGCTTTGGAAAAGAGTCTGAAAGTGACTATCTCTATCCAAAGAACCTGAAAATGTCCGTCGTAAAGCTTGTTTCTCATGAACAGTGTATGCAGCCCCACTACTATGGCTCTGAAATTAATTATAAAATGCTGTGTGCTGCGGACCCAGAGTGGAAAACAGATTCCTGCAAGGGCGATTCTGGAGGACCGCTTATCTGTAACATCGAAGGCCGCCCAACTCTGAGTGGGATTGTGAGCTGGGGCCGAGGATGTGCAGAGAAAAACAAGCCCGGTGTCTACACGAGGGTCTCACACTTCCTGGACTGGATTCAATCCCACATTGGAGAAGAGAAAGGTCTGGCCTTCTGATGGCCCTCAGGTAGCTGAGGGAAGAAACAGATGGGTCACTTGTTCCCATGCTGACCGTCCTCTCTGCAACAGAGTCGTCAAATGGAGGGAAGAAGCTGAAAAGACAGGTTTTGCATTGATCCTCTGCTGTGCTGCCCACCAGGGTGAGCGCCAATAGCATTACCCTCAGACACAGGCCTGGGTGCTGGCCATCCAGACCCTCCCGACCAGGATGGAAAGTTGGTCCTGACTCAGGATGCTATAGACCAGGAGTTGCCTTTTTATGGACTAAAGCCATCTGCAGTTTAGAAAACATCTCCTGGGCAAGTGTAGGAGGAGAGCTGTTTCCCTTAATGGGTCATTCATGAGATCTGCTGTTGGGAAATAAATGATTTCCCAATTAGGAAGTGCAACAGCTGAGGTATTGTGAGGGTGCTTGTCCAATATGAGAACGGTAGCTTGAGGAGTAGAGACACTAACGGCTTGAGGGAACAGCTCTAGCATCCCATGAATGGATCAGGAAATGTTATATTTGTGTGTATGTTTGTTCACTCTGCACAGGCTGTGAGTATAAGCCTGAGCAAAAGCTGGTGTATTTCTGTATCTAACTGCAAGTCTAGGTATTTCCCTAACTCCAGACTGTGATGCGGGGCCATTTGGTCTTCCATGTGATGCTCCACGTGAATGTATCATTCCCGGGCGTGACCCGTGACTAGCACTAAATGTCGGTTTCACTTTTTATATAGATGTCCACTTCTTGGCCAGTTATCTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTACTAATTAGCCTAGTTCATCCAATCCTCACTGGGTGGGGTAAGGACCACTTCTACATACTTAATATTTAATAATTATGTTCTGCTATTTTTATTTATATCTATTTTTATAATTCTGAGTAAAGGTGATCAATAAATGTGATTTTTCTGAAG</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell surface</CellLocal>
      <Ontology_ID>GO:0009986</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Plau</Gene_Name>
    <Gene_ID>18792</Gene_ID>
    <Genbank_ACCN>NM_008873</Genbank_ACCN>
    <Protein_ACCN>NP_032899</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/18792</Gene_URL>
    <EMBL_ID>ENSMUSG00000021822</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure-based engineering of species selectivity in the uPA-uPAR interaction</PDB_Title>
      <PDB_ID>3LAQ</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LAQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based engineering of species selectivity in the interaction between urokinase and its receptor: implication for preclinical cancer therapy.</PubMed_Title>
      <Author>Lin, L., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:10982-10992</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20133942?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_Class>Class 2: Mainly Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/3laq</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Liu Z, et al. Biochemistry. 2012 Sep 5. [Epub ahead of print]</Site_Reference>
      <PubMed_ID>22950516</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.21.73</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/21/73.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>